These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma. Keller J; Schwartz TL; Lizalek JM; Chang ES; Patel AD; Hurley MY; Hsueh EC Cancer Med; 2019 May; 8(5):2205-2212. PubMed ID: 30950242 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes in a Multicenter, Prospective Cohort Evaluating the Prognostic 31-Gene Expression Profile for Cutaneous Melanoma. Hsueh EC; DeBloom JR; Lee JH; Sussman JJ; Covington KR; Caruso HG; Quick AP; Cook RW; Slingluff CL; McMasters KM JCO Precis Oncol; 2021; 5():. PubMed ID: 34036233 [TBL] [Abstract][Full Text] [Related]
6. Risk Stratification of Patients with Stage I Cutaneous Melanoma Using 31-Gene Expression Profiling. Martin BJ; Covington KR; Quick AP; Cook RW J Clin Aesthet Dermatol; 2021 Sep; 14(9):E61-E63. PubMed ID: 34980974 [TBL] [Abstract][Full Text] [Related]
7. Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study. Dillon LD; McPhee M; Davidson RS; Quick AP; Martin B; Covington KR; Zolochevska O; Cook RW; Vetto JT; Jarell AD; Fleming MD Curr Med Res Opin; 2022 Aug; 38(8):1267-1274. PubMed ID: 35081854 [TBL] [Abstract][Full Text] [Related]
8. Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria. Gastman BR; Gerami P; Kurley SJ; Cook RW; Leachman S; Vetto JT J Am Acad Dermatol; 2019 Jan; 80(1):149-157.e4. PubMed ID: 30081113 [TBL] [Abstract][Full Text] [Related]
9. The 31-gene expression profile stratifies recurrence and metastasis risk in patients with cutaneous melanoma. Jarell A; Skenderis B; Dillon LD; Dillon K; Martin B; Quick AP; Siegel JJ; Rackley BB; Cook RW Future Oncol; 2021 Dec; 17(36):5023-5031. PubMed ID: 34587770 [TBL] [Abstract][Full Text] [Related]
11. A Dermatologist's Guide to Implementation of Gene Expression Profiling in the Management of Melanoma. Kwatra SG; Hines H; Semenov YR; Trotter SC; Holland E; Leachman S J Clin Aesthet Dermatol; 2020 Nov; 13(11 Suppl 1):s3-s14. PubMed ID: 33349788 [No Abstract] [Full Text] [Related]
12. Estimation of Prognosis in Invasive Cutaneous Melanoma: An Independent Study of the Accuracy of a Gene Expression Profile Test. Greenhaw BN; Zitelli JA; Brodland DG Dermatol Surg; 2018 Dec; 44(12):1494-1500. PubMed ID: 29994951 [TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Masarwy R; Shilo S; Carmel Neiderman NN; Kampel L; Horowitz G; Muhanna N; Mansour J Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173922 [TBL] [Abstract][Full Text] [Related]
14. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients. Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264 [TBL] [Abstract][Full Text] [Related]
15. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test. Hsueh EC; DeBloom JR; Lee J; Sussman JJ; Covington KR; Middlebrook B; Johnson C; Cook RW; Slingluff CL; McMasters KM J Hematol Oncol; 2017 Aug; 10(1):152. PubMed ID: 28851416 [TBL] [Abstract][Full Text] [Related]
16. Do Largest Basal Tumor Diameter and the American Joint Committee on Cancer's Cancer Staging Influence Prognostication by Gene Expression Profiling in Choroidal Melanoma. Demirci H; Niziol LM; Ozkurt Z; Slimani N; Ozgonul C; Liu T; Musch DC; Materin M Am J Ophthalmol; 2018 Nov; 195():83-92. PubMed ID: 30081017 [TBL] [Abstract][Full Text] [Related]
17. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification. Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997 [TBL] [Abstract][Full Text] [Related]
18. CORRELATION OF GENE EXPRESSION PROFILE STATUS AND AMERICAN JOINT COMMISSION ON CANCER STAGE IN UVEAL MELANOMA. Berry DE; Schefler AC; Seider MI; Materin M; Stinnett S; Mruthyunjaya P; Retina; 2020 Feb; 40(2):214-224. PubMed ID: 31972790 [TBL] [Abstract][Full Text] [Related]
19. Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I-II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study. Podlipnik S; Boada A; López-Estebaranz JL; Martín-González MM; Redondo P; Martin B; Quick AP; Bailey CN; Kurley SJ; Cook RW; Puig S Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205808 [TBL] [Abstract][Full Text] [Related]